FLII and Ewing sarcoma: PARP-1 expression and activity are also required for cancer cell invasion (Figure 1) mediated by ETS transcription factors – whose fusion products drive Ewing’s sarcoma, acute myeloid leukemia, and prostate cancer – and the Ewing’s sarcoma fusion protein EWS-FLI (14, 15).